David Arcia-Anaya

2PUBLICATIONS
3CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 16, 2023
Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1.

Gessa Sugiyarto, Doreen Lau, Samuel Luke Hill

|Jan 03, 2023
STAT5A antagonizes TOX in CD8+ T cell exhaustion.

David Arcia-Anaya, Tim Elliott

Pageof 1